These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 22992669)

  • 1. Individualized dosing with anesthetic agents.
    Lemmens HJ; Stanski DR
    Clin Pharmacol Ther; 2012 Oct; 92(4):417-9. PubMed ID: 22992669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative pharmacology in morbid obesity.
    Lemmens HJ
    Curr Opin Anaesthesiol; 2010 Aug; 23(4):485-91. PubMed ID: 20531173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anesthetic drugs and bariatric surgery.
    Lemmens HJ; Brodsky JB
    Expert Rev Neurother; 2006 Jul; 6(7):1107-13. PubMed ID: 16831123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. My child is unique; the pharmacokinetics are universal.
    Anderson BJ
    Paediatr Anaesth; 2012 Jun; 22(6):530-8. PubMed ID: 22226125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safe and effective variability-a criterion for dose individualization.
    Holford NH; Buclin T
    Ther Drug Monit; 2012 Oct; 34(5):565-8. PubMed ID: 22960736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antimicrobial agents and renal elimination: towards individual dosage adjustment?].
    Willi-Robatel C; Senn L; Livio F; Zanetti G; Marchetti O; Buclin T
    Rev Med Suisse; 2012 Apr; 8(338):894-900. PubMed ID: 22611626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local anesthetics in dental practice.
    Milam SB; Giovannitti JA
    Dent Clin North Am; 1984 Jul; 28(3):493-508. PubMed ID: 6589180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized dosing regimens in children based on population PKPD modelling: are we ready for it?
    Knibbe CA; Danhof M
    Int J Pharm; 2011 Aug; 415(1-2):9-14. PubMed ID: 21376791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New concepts in pharmacokinetics and pharmacodynamics.
    Gepts E
    Acta Anaesthesiol Belg; 1997; 48(4):199-204. PubMed ID: 9526594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tips and traps analyzing pediatric PK data.
    Anderson BJ; Holford NH
    Paediatr Anaesth; 2011 Mar; 21(3):222-37. PubMed ID: 21320233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized compared with conventional dosing of enoxaparin.
    Barras MA; Duffull SB; Atherton JJ; Green B
    Clin Pharmacol Ther; 2008 Jun; 83(6):882-8. PubMed ID: 17928819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug dosage individualization based on a random-effects linear model.
    Diaz FJ; Cogollo MR; Spina E; Santoro V; Rendon DM; de Leon J
    J Biopharm Stat; 2012; 22(3):463-84. PubMed ID: 22416835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian rhythms and their development in children: implications for pharmacokinetics and pharmacodynamics in anesthesia.
    Potts AL; Cheeseman JF; Warman GR
    Paediatr Anaesth; 2011 Mar; 21(3):238-46. PubMed ID: 20561229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosing modifications of targeted cancer therapies in patients with special needs: evidence and controversies.
    Ng T; Chan A
    Crit Rev Oncol Hematol; 2012 Jan; 81(1):58-74. PubMed ID: 21429761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational opioid dosing in the elderly: dose and dosing interval when initiating opioid therapy.
    Gupta DK; Avram MJ
    Clin Pharmacol Ther; 2012 Feb; 91(2):339-43. PubMed ID: 22205194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrations.
    Barras MA; Duffull SB; Atherton JJ; Green B
    Ther Drug Monit; 2010 Aug; 32(4):482-8. PubMed ID: 20592650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of high-dose cyclophosphamide, cisplatin, and carmustine pharmacokinetics with survival, toxicity, and dosing weight in patients with primary breast cancer.
    Petros WP; Broadwater G; Berry D; Jones RB; Vredenburgh JJ; Gilbert CJ; Gibbs JP; Colvin OM; Peters WP
    Clin Cancer Res; 2002 Mar; 8(3):698-705. PubMed ID: 11895898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualization of drug therapy: history, present state, and opportunities for the future.
    Lesko LJ; Schmidt S
    Clin Pharmacol Ther; 2012 Oct; 92(4):458-66. PubMed ID: 22948891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The creative psychopharmacotherapy and personalized medicine: The art & practice of the learning organization.
    Jakovljević M
    Psychiatr Danub; 2010 Jun; 22(2):309-12. PubMed ID: 20562771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced technologies and devices for inhalational anesthetic drug dosing.
    Meyer JU; Kullik G; Wruck N; Kück K; Manigel J
    Handb Exp Pharmacol; 2008; (182):451-70. PubMed ID: 18175104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.